Humaneva CEO - Tomasz D?browski WARSAW, Poland, September 27, 2024 (Newswire.com) - Humaneva Inc. has entered into a ...

Baxter International Inc. (NYSE:BAX), a leading global medtech company, today unveiled its next generation airway clearance ...

Future Biotechnologists is holding an outreach event on 16th October 2024 at Nower Hill School in Pinner. Dedicated to inspiring students to pursue a career in the life sciences, Future ...

Pelvic health startup Hyivy Health poised to offer better solutions to the 300M patients with pelvic floor dysfunction causing chronic pelvic pain and the clinicians who treat them.KITCHENER, ON / ...

First-ever DehydraTECH-processed tirzepatide from Zepbound® to be tested in a swallowed oral format KELOWNA, BC / ACCESSWIRE / September 27, 2024 / Lexaria Bioscience Corp. (NASDAQ:LEXX)(NASDAQ:LEXXW) ...

The CDC reports that healthcare workers in the U.S. face an estimated 385,000 needlestick and sharps-related injuries every ...

Compassion Center Austin introduces Texans to natural pain management and opioid risk reduction through the Texas Compassionate Use Program (TCUP). By integrating low-THC cannabis and ...

AGM/EGMShare price target 12.50 euros: Annual General Meeting supports SYNBIOTIC's growth plans with over 99 percent approval 27.09.2024 / 11:19 CET/CESTThe issuer is solely responsible for the ...

Regulatory Approval/MiscellaneousFormycon and Fresenius Kabi receive European Commission approval for FYB202/Otulfi® (ustekinumab) for the treatment of serious inflammatory diseases 27.09.2024 / 09:00 ...

LONDON, UNITED KINGDOM / ACCESSWIRE / September 27, 2024 / Hemogenyx Pharmaceuticals plc (LSE:HEMO), the biopharmaceutical group developing therapies designed to transform blood disease treatment, ...

IRVINE, CA / ACCESSWIRE / September 26, 2024 / enVVeno Medical Corporation (NASDAQ:NVNO) ("enVVeno" or the "Company"), a company setting new standards of care for the treatment of venous disease, ...

Consolidated net revenue was $81.0 million versus $107.4 million in the prior year period. The change primarily reflects the Company's wind down of its Consumer Health Segment as part of the strategic ...